| ID | Sequence | Length | GC content |
|---|---|---|---|
| GGCCCGCGCGCUCCUGGGCGGGGGAUGUUGUGAUGGAGAAGCCGCGGCG… | 2666 nt | 0.6080 | |
| AGACGCUCUGCCCUGGUGAGAAGGGGGCGGGAUGAGCUUUUCUCUGCAG… | 2010 nt | 0.5935 | |
| UCAUUUGGAAGCUGAGGAUGGUGAAGCACCCUGCCUGAAUAACUCUCGU… | 2114 nt | 0.5875 | |
| GAGACGCUGCAGCCUAGCUGGGCCCUGGCAGGUGAGGGGUGGGGGGUGG… | 2162 nt | 0.5870 | |
| AGACGCUCUGCCCUGGUGAGAAGGGGGCGGGAUGAGCUUUUCUCUGCAG… | 2004 nt | 0.5938 | |
| AAGAGUUAGAGGACGCAUGAGCGGGUUACAGGGUUGGAGUGGUGUGGCU… | 1906 nt | 0.5871 | |
| GAGACGCUGCAGCCUAGCUGGGCCCUGGCAGGUGAGGGGUGGGGGGUGG… | 2122 nt | 0.5877 | |
| CUUCCCCGCGCGGCCGCGGCGCCGCACAGCCGCCGCCAUUCGGGCUCCA… | 2658 nt | 0.6114 |
The protein encoded by this gene is a member of the Fe65 protein family. It is an adaptor protein localized in the nucleus. It interacts with the Alzheimer's disease amyloid precursor protein (APP), transcription factor CP2/LSF/LBP1 and the low-density lipoprotein receptor-related protein. APP functions as a cytosolic anchoring site that can prevent the gene product's nuclear translocation. This encoded protein could play an important role in the pathogenesis of Alzheimer's disease. It is thought to regulate transcription. Also it is observed to block cell cycle progression by downregulating thymidylate synthase expression. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Mar 2012]
A study in rats demonstrated that the APBB1 mRNA, quantified via real-time PCR after traumatic brain injury, serves as a molecular marker for diagnosing diffuse axonal injury [Bauer DOI:10.1016/j.fsigen.2006.11.002]. This beta-amyloid precursor protein-binding protein is suggested as a marker for traumatic brain injury, with its quantitation applicable in forensic molecular pathology to investigate the pathophysiology of fatal processes [Maeda et al. DOI:10.1016/J.Forsciint.2010.07.024].